Trials / Sponsors / Actinium Pharmaceuticals
Actinium Pharmaceuticals
Industry · 6 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Radioimmunotherapy Conditioning With 131I- Apamistamab for Allogeneic Transplant in Relapse/Refractory AML Acute Leukemia, Myeloid Leukemia, Acute Myelogenous Leukemia | Phase 2 / Phase 3 | 2026-01-01 |
| Withdrawn | Venetoclax, Azacitidine, and Lintuzumab-Ac225 in AML Patients Acute Myeloid Leukemia, Relapsed Adult AML | Phase 1 / Phase 2 | 2023-03-01 |
| Unknown | Venetoclax and Lintuzumab-Ac225 in AML Patients Acute Myeloid Leukemia, Relapsed Adult AML | Phase 1 / Phase 2 | 2020-01-15 |
| Terminated | A Phase I Study of Lintuzumab-Ac225 in Patients With Refractory Multiple Myeloma Refractory Multiple Myeloma | Phase 1 | 2016-12-01 |
| Active Not Recruiting | Study of Iomab-B vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory Acute Myeloid Leu Acute Myeloid Leukemia, Leukemia, Acute Myeloid, Myeloid Leukemia, Acute | Phase 3 | 2016-06-01 |
| Completed | Lintuzumab-Ac225 in Older Acute Myeloid Leukemia (AML) Patients AML | Phase 1 / Phase 2 | 2012-10-01 |